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N-Benzyl-4, 5-O-diprotected-3, 6-dihydroxyazepanes 18 and Ib prepared by the reaction of 1, 2
: 5, 6-dianhydro-3, 4-O-isopropylidene-L-iditol and benzylarnine undergo a skeletal rearrangement to
furnish the piperidine derivatives 3a and 3b under Mitsunobu condition. On the contrarN-benzyl-3,
6-diprotected-4, 5-dihydroxyazepane Sc under identical conditions (Mitsunobu conditions) furnishes
a pyrrolidine derivative 7. Interestingly, azepane Ib undergoes an intramolecular nucleophilic substi-
tution in the absence of an external nucleophile (benzoic acid) under Mitsunobu condition to give
the bicyclic compound 4a.
Polyhydroxylated - piperidines and pyrrolidines
constitute a major class of glycosidase and glyco-
syl transferase inhibitors I. In recent years there
has been increasing interest in the synthesis of
these azasugars due to their chemotherapeutic
utility in the treatment of diabetes", cancer", obes-
ity" and AIDS5.6. Recently, the synthesis of six-
and seven-membered azasugars in nearly 1:1 ratio
has been reported by the reaction of dianhydrosu-
gars with arnines 7• Some of the seven-membered
polyhydroxylated heterocyclic compounds have
been reported to undergo rearrangement to yield
six-membered polyhydroxy heterocyclic com-
pounds either via mesylation" of one of the hy-
droxy groups or by Mitsunobu reaction",
We have reported recently'? the reaction of 1, 2
: 5, 6-dianhydro-3, 4-G-isopropylidenehexitols
with benzylarnine to furnish substituted azepane
derivatives as the only isolable products in good
yields (64-88%). Direct attempts to convert the
appropriate dianhydrosugars selectively to polyhy-
droxylated piperidine or pyrrolidine derivatives
were not encouraging. Therefore, we attempted a
selective conversion of polyhydroxyazepanes pre-
pared earlier'? to either a six-membered piperi-
dine or a five-membered pyrrolidine derivative.
Here we report the transformation of polyhydrox-
yazepanes to deoxynojirimycin and pyrrolidine
derivatives under Mitsunobu condition.
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Results
1, 2:5, 6-Dianhydro-3, 4-G-isopropylidene-L-
iditol was treated with benzylarnine in refluxing
THF to afford (35, 4R, 5R, 65)-N-benzyl-3, 4, 5,
6-tetrahydroxy-4, 5-G-isopropylideneazepane 1a
in 64% yield!". Treatment of la under Mitsunobu
condition (1.5 equiv. PPh3-DEAD-PhCOOH in
THF at ca 25°C for 48 hr) provided a mixture of
three products in 1:1:1 ratio, the structure of
which has been established as dibenzoyl piperi-
dine derivative 3a, 3, 6-dibenzoylazepane deriva-
tive 5a and monobenzoyl azepane 2a based on
spectral data. The structures of 2a, 3a and 5a
were further confirmed by exhaustive benzoyla-
tion of 1a and 2a to 5a using benzoyl chloride in
pyridine in 85% yield at ca O'C. In contrast, when
azepane Ib Was treated with Ph3P-DEAD-
PhCOOH (Mitsunobu condition) only the piperi-
dine derivative 3b (25%) was obtained along with
the unreacted azepane Ib (Scheme I). Products
were characterized by spectral data and by com-
parison with authentic material prepared through
an independent route.
When the reaction of 1b was performed with
PPh3-DEAD in the absence of benzoic acid, a
65% yield of the bicyclic compound 4a was Iso-
lated as the only product. The structure of 4a was
established by spectral data and further transfor-
mation of 4a to the corresponding known diol 4b
(40%) after removal of THP protecting group",
Further, the azepane 5a was treated with 80%
aqueous CF3COOH to furnish N-benzyl-3, 6-dib-
enzoyl-d, 5-dibydroxyazepane 5c in 97% yield.
Treatment of azepane 5c under Mitsunobu condi-
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tion (1.5 eq, PPh3-DEAD-PhCOOH in THF at
room temperature for 48 hr) furnished a mixture
of two products, characterized as the pyrrolidine
derivative 7 and N-benzyl-3, 4, o-tribenzoyl-
5-hydroxyazepane 8 in 3:4 ratio based on analyti-
cal data (Scheme II).
The structures of' 7 and 8 were further con-
firmed by converting them to the corresponding
tetrabenzoyl derivatives 9 and 10 respectively and
by comparison with authentic samples prepared
by independent routes.
Discussion
Since the trans-acetonide, as the protecting
group, played a crucial role in the selective trans-
formation of 1, 2 : 5, 6-dianhydro-3, 4-0-
isopropylidenehexitol'? to azepane 1a, further














a) p.p = Me2C : R = OCOPh

















sunobu condition was attempted. The possible
transformations of azepane derivatives la, lb and
Sc are shown in Scheme III.
Under Mitsunobu condition, an intermediate
aziridinium ion I' is formed. The nucleophilic
PhCOO- ion attacked either at C-2 position lead-
ing to the formation of a piperidine derivative 3a
or at C-3' centre affording 3~benzoyl substituted
azepane 2a and 3, 6-dibenzoyl substituted aze-
pane Sa. The latter may arise by a double Mit-
sunobu reaction of la or a further Mitsunobu
reaction of 2a. Although Mitsunobu reaction in
this case is expected to proceed via a double in-
version pathway leading ultimately to retention of
the configuration atthe reacting carbon centre (C-
3), the azepanes 2a and Sa were found to under-
go partial racemization. This may be due to the






formation of the aziridinium ion I.' which may
adopt a partial planar conformation and the nu-
cleophile may react from either face to furnish
partially the racemized azepanes 2a and 5a. In
contrast, the piperidine derivative 3a may not un-
dergo racemization, since the nucleophilic attack
occurs at C-2 centre which is not chiral. On the other
hand, N-benzyl-4, 5-O-bistetrahydropyranyl-3,
6-dihydroxyazepane 1b undergoes smooth skeletal
rearrangement under Mitsunobu condition to furnish
the piperidine derivative 3b via a similar aziridinium
intermediate l' as shown in Scheme III. Interestingly,
when azepane 1b is treated under identical condi-
tions in the absence of benzoic acid, the intermediate
aziridinium ion I.' may undergo an intramolecular
rearrangement in the absence of external nucleophile
(benzoic acid), and the OH group present at C-3
centre in the molecule may act as an internal nucleo-
phile to give 4a as the sole product (Scheme III). Such
an intramolecular rearrangement is not observed
when 3, 4-hydroxy groups are protected as trans-
acetonide as in the case of azepane la.
In contrast, when hydroxy groups at C-4 and
C~5 positions of azepane 5c are unprotected and
C-3 and C-6 positions are protected as dibenzoyl
derivative, 5c undergoes a rearrangement via an
azetidinium intermediate Sc' (Scheme III). The
benzoic acid acts as a nucleophile and may react
either at C-2 centre to furnish the pyrrolidine der-












Thus, we have been able to prepare deoxynojirimy-
cin derivative 3b and the pyrrolidine derivative 7
from a common starting material azepane, which is
readily available from dianhydrosugar.
Experimental Section
General. (3S, 4R, 5R, 6S)-N-Benzyl-2, 4, 5, 6-
tetrahydroxy-4, 5-o-isopropylidene azepane la
was prepared from the corresponding 1, 2:5, 6-di-
anhydro-3, 4-O-isopropylidene-L-idito) by a re-
ported procedure 10. All the chemicals were dis-
tilled or recrystallised before use and anhydrous
solvents were freshly prepared by standard proce-
dure. TLC was performed on silica gel plates
(60F254, Merck). Flash chromatography was per-
formed on silica gel (SRL, 230-400 or 400-200
mesh). Melting points were recorded on a Veego
melting point" apparatus and are uncorrected. IH
NMR and 13C NMR spectra were recorded on a
Varian Gemini 200 MHz spectrometer and signals
are reported in parts per million, ppm. IR spectra
were recorded on a Perkin-Elmer FT ffi.-1600
spectrometer. Mass spectra were obtained on a
HP 5989A mass spectrometer. Stereochemical as-
signments are based on the stereochemistry of the
starting sugar derivative.
Mitsunobu reaction of (3S, 4R, 5R, 6S)-N-
benzyl-4, 5-o-isopropylidene-3, 6-dihydroxyaze-
pane la. A mixture of azepane 1a (586 mg, 2.0
mmoles), PPh3 (786 mg, 3.0 mmoles), PhC02H
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(366 mg, 3.0 mmoles), DEAD (472 ~L, 5.22 mg,
3.0 mmores) and TIIF (10 mL) was stirred at
room temperature for 8 hr. The solvent was evap-
orated under reduced pressure and the residue
flash chromatographed over silica gel using a mix-
ture of pet. ether-ethyl acetate (3:1) to afford the
dibenzoylazepane 5a (250 mg, 25%); [all? +
8.00 (c 0.37, CHCI3); IR (KBr) : 1709 em-I; IH
NMR (CDCI3) : 6 1.44 (s, 6H), 2.88 (dd, J= 6
and 12 Hz, 2H), 3.20 (dd, J= 6 and 12 Hz, 2H),
3.70 (q, J= 14 Hz, 2 H), 4.30-4.42 (m, 2H), 5.18-
5.32 (ill, 2H), 6.80-7.66 (rn, 11H), 8.00 (d, J=6
HZ,4H); 13CNMR(CDCl3):626.9,59.3,63.5, 74.5,
77.8,110.3,127.1; 128.1, 128.6, 129.8, 132.9, 138.1,
165.7; MS (relative intensity) :m1z 502 (M+ + 1,3%),
105 (90%),91 (100%).
Further elution of the column with pet. ether-
ethyl acetate (2:1) afforded the dibenzoylpyrroli-
dene derivative 3a (200 mg, 20%); IR (KBr):
1718 cm"": IH NMf{-(CDCl3) : 1.36 (s, 3H), f50
(s, 3H), 2.90 (dd, J=4 and 12 Hz, 2H), 3.06-3.30
(m, 2H), 3.76 (q, J= 10 Hz, 2H), 4.22(d, J= 6 Hz,
1H), 5.06 (t, J= 6 Hz, 1H), 5.22 (brs, 1H), 5.62
(brs, 1H), 7.00-7.12 (m, 3H), 7.26-7.34 (m, 2H),
7.42-7.70(m, 6H), 8.06 (d, J=6 Hz, 2H), 8.16 (d,
J= 6 Hz, 2H); 13C NMR(CDCI3): 6 26.7, 27.1,
59.4, 59.8, 63.7, 69.6, 75.9, 76.3, 76.9, 110.1,
126.9, 128.1, 128.4, 129.6, 129.7, 132.9, 138.7,
165.6, 165.9; MS (relative intensity) : m/z 502
(M+ + 1, 1%), 105(90%),91 (100%).
Further elution of the column with pet. ether-
ethyl acetate (1:1) afforded the monobenzoylaze-
pane 2a (250 mg, 30%); IR (Neat): 3454, 1718
em-I; IH NMR (CDCI3): 6 1.46 (s, 6H), 2.48-
3.22 (m, 5H), 3.68 (q, J= 10 Hz, 2H), 3.88 (d,
J=6 Hz, 2H), 4.38 (t, J=6 Hz, 1H), 5.08-5.18
(m, 1H), 7.00-7.60 (m, 8H), 7.98 (d, J=6 Hz,
2H); MS (relative intensity) : rn/z 398 (M+ + 1,
1%) 105 (50%), 91 (100%).
Benzoylation of (3S, 4R, 5R, 65)-N-benzyl-4,
5-o-isopropylidene-3, 6-dihydroxyazepane la.
To a solution of azepane la (2.93 g, 10 mmoles)
in dry pyridine (30 mL) was added benzoyl chlo-
ride (3.5 mL, 4.2 g, 30 mmoles) at ca O°C under
an argon atmosphere. The reaction mixture was
stirred at room temperature for 12 hr followed by
quenching with ice (50 g). The mixture was
poured into 6N HCI (20 mL) and extracted with
ethyl acetate (3 x 30 mL). The organic layer was
washed with brine (2 x 30 mL) dried, filtered and
the filtrate evaporated under reduced pressure to
give a residue which was flash chromatographed
over silica gel using pet. ether-ethyl acetate (2:1)
as eluent to afford 5a (4.25 g, 85%) as a white
solid, m.p. 160-62°; [all? + .43.3° (cO.75, CHCl3).
Benzoylation of (3S-, 4R, 5R, 65)-N-benzyl-4,
5- o.isopropylidene- 3-benzoyl- 6-hydroxyazepane
2a. Following the above methodology, 2a (216 -
mg, 0.5 mmole) was converted into Sa (218 mg,
87%) as a white solid, m.p. 160-62°.
Preparation of (3S, 4R, 5R, 65)-N-benzyl-3,
6-o-dibenzoyl-4, 5-dihydroxyazepane 5c. An
aqueous solution of CF3C02H (80%, 25 mL) was
added dropwise to a flask containing azepane 5a
(4.25 g, 8.5 mmoles) at ca O°C and the reaction
mixture stirred for 5 hr at room temperature.
Trifluoroacetic acid was removed under reduced
pressure and the syrupy material purified by silica
gel column chromatography using pet. ether-ethyl
acetate (1:1) as eluent to afford diol 5c (3.8 g,
97%) as a white solid, m.p. 73-74°; [a]b5 + 13.18°
(e, 0.22, MeOH); IR (KBr) : 3411, 1721 cm "; IH
NMR (CDCI3) : 6 3.30-3.54 (m, 4H), 3.98-4.32
(m, 4H), 5.14-5.40 (bs, 2H), 5.42-5.60 (bs, 2H),
7.20-7.64 (m, 11H), R.OO (d, .1=6 Hz, 4H); l3e
NMR (CDCI3) : 6 52.7, 62..1,71.5, 73.4, 128.4,
128.9, 129.1, 129.7, 129.9, 130.8, 133.5, 165.9;
MS (relative intensity) : wz 340 (M+ + i -122:
5%),105 (56%), 91 (100%).
Preparation of (3S, 4R, 5R, 65)-N-benzyl-4,
5- o-bistetrahydropyranyl- 3, 6-dihydroxyazepane
lb. To a solution of the azepane 5c (3.8 g, 8.2
mmoles) in dry CH2Cl2 (20 mL) was added di-
hydropyran (2.2 mL, 2.02 g, 24 mmoles) and PPTS
(1.0 g, 4 mmoles) and the mixture stirred for
6 hr at room temperature under an argon atmos-
phere. The reaction mixture was diluted with
ethyl acetate (25 mL) and washed with saturated
NaHC03 solution and brine. The organic layer
was dried, filtered and concentrated under re-
duced pressure. The residue was purified by silica
gel column chromatography using pet. ether-ethyl
acetate (2:1) as eluent to afford (3S, 4R, 5R, 6S)-
N-benzyl- 3, 6- O-dibenzoyl-4, 5- O-bistetrahydrop-
yranylazepane 5b (3.2 g, 62%) as a viscous oil; IR
(Neat): '1721 cm"; IH NMR (CDC13):
61.20-1.80 (m, 12H), 2.80-3.20 (m, 4H), 3.22-
3.52 (m, 2H), 3.62-3.98 (m, 4H), 4.1O-4.42(m,
2H),4.72-5.00 (m, 2H), 5.30-5.70(m, 2H), 7.00-7.70
(m, 11H), 7.80-8.22 (m, 4H); MS (relative intensity):
m1z 544 (M+ - 85, 4%),105 (80%),91 (100%).
The azepane 5b (3.14 g, 5 mmoles), obtained in
the previous step, was dissolved in dry MeOH
(20 mL) and anhydrous K2C03 (3.45 g, 25
mmoles) was added to it. The mixture was stirred for
10 hr at room temperature under an argon atmos-
phere, filtered and the filtrate concentrated under
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reduced pressure. The residue was purified by si-
lica get column chromatography using pet. ether-
ethyl acetate (1:3) as eluent to afford azepane Ib
(1.1 g, 52%) as .a viscous oil; IR (Neat): 3421,
1026 cm-I; IH NMR (CDCI3): 6 1.42-1.92 (m,
12 H), 2.46-3.24 (m, 6 H), 3.32-3.84 (m, 1OH),
3.9-4.16 (m, 1H), 4.50-4.80 (rn, 1H), 7.20-7.42
(m, 5H); MS (relative intensity) : mJz 422 (M+
+ 1,1%),320 (43%),91 (100%).
Mitsunobu reaction of (35, 4R, SR, 65)-N-
benzyl-a, S-D-bistetrahydropyranyl-3, 6-dihy-
droxyazepane 1b. The Mitsunobu reaction was
carried out by the method as described for la us-
ing the azepane Ib (Ig, 2.37 mmoles), PPh3 (0.94
g, 3.55 mmoles), PhC02H (0.44 g, 3.55 mmoles)
and DEAD (0.6 mL, 0.62 g, 355 mmoles) in THF
(10 mL) which afforded the piperidine derivative
3b (290 mg, 25%) besides the unreacted Ib (270
mg, 22%) after chromatographic separation. The
piperidine derivative 3b showed IR (KBr) : 3298,
1724 cm-I; IH NMR (CDCI3) :'6 1.40-1.80 (m,
12 H), 2.70-3.10 (rn, 3 H), 3.30-3.64 (m, 2 H),
3.70-3.96 (m, 2H), 4.00-4.24 (m, 6H), 4.42-4.56
(m, 2H), 4.60-4.40 (rn, 1H), 4.88-5.00
(m, 1H), 7.26-7.62 (rn, 8H), 8.00-8.18
(rn, 2H); MS: (relative intensity) : m/z 526 (M+ +
1,1%),390 (20%), 91 (100%).
Preparation of (2R, 3R, 4R, 55)-1\'
benzyl-2-(benzoyloxymethyl)-3, 4, 5-tri-D-
benzoyl piperidine 6. To a solution of the piperi-
dine 3b (220 mg, 0.4 mmole) in MeOH-H20 (9:1,
2 mL) was added p-TsOH (63 mg, 0.25 mmole)
and the mixture stirred for 10 hr at room temper-
ature. The solvent was removed under reduced
pressure and the residue purified by silica gel co-
lumn chromatography using ethyl acetate-MeOH
(1:1) as eluent to afford (2R, 3R, 4R, 55)-N-
benzyl-2-(benzoyloxymethyI)-3, 4, 5-trihydroxy-
piperidine 3c (88 mg, 62%) as a syrup oil; IR
(Neat): 3404,1717 cm-I; IH NMR (CD30D): 6
2.90-3.20 (m, 3H), 3.42-3.82 (m, 5H), 4.00-4.30
(m, 3H), 4.46 (d, J= 6 Hz, 2H), 7.16-7.76(m, 8H),
8.06 (d, J= 6 Hz, 2H); MS (relative intensity) :
m/z 358 (M+ + 1,1 %),222, (10%),91 (100%).
The piperidine derivative 3c, obtained from the
previous experiment (96 mg, 0.25 mmole), was
benzoylated by the method described earlier, us-
ing benzoyl chloride (187 ul, 227 mg, 1.5
mmoles) in dry pyridine (2 mL) to afford 6 (80
mg, 50%) as a viscous oil; IR (CHCI3) : 1688
cm-I; IH NMR (CDCI3) : 62.84-3.30 (m, 3H),
3.42-3.70 (m, 2H), 4.68-4.82 (m, 2H), 5.44(d,
J=4 Hz, 1H), 5.68 (d, J=4Hz, 1H), 5.90 (d, J=4
Hz, 1H), 7.12-7.64 (m, 17H), 7.88-8.20 (rn, 8H);
MS (relative intensity) : mJz 670 (M+, 0.5%), 105
(100%).
Mitsunobu reaction of (35, 4R, SR, 6S)-N-
benzyl-4, 5-D-bistetrahydropyranyl-5, 6-dihy-
droxyazepane 1b in the absence of benzoic acid.
The Mitsunobu reaction was carried out by the
method as described for 1a using the azepane 1b
(295 mg, 0.7 mmole). DEAD (132 !!L, 147 mg,
0.84 mmole) and PPh3 (220 mg, 0.84 mmole) in
dry THF (3 mL) to afford the bicyclic compound
4a (182 mg, 65%) as viscous oil. Tetrahydropyra-
nyl group was removed by the method described
above using p-TsOH (20 mg, 0.1 mmole) and
H2b-MeOH (1:9, 5 mL) to give §-oxa-3N-
benzylbicyelo[3.2.1 joctane-o, 7-diol 4bl2 (48 mg,
40%) as a pale yellow solid (hygroscopic); IR
(KBr):. 3378 cm-I; IH NMR (CDCI3+ CD30D) :
63.08-3.42 (rn, 4H), 3.56-3.90(m, 2fI), 4.10 (brs,
1H), 4.24 (brs, 1H), 4.30 (d, J= 8 Hz, 1H), 4.42
(d, J= 6 Hz, 1H), 4.54 (brs, 2H), 7.50 (brs, 5H);
MS (relative intensity): mJz 235 (M+, 6%), 91
(100%).
Mitsunobu reaction of (35, 4R, SR, 6S)-N-
benzyl-3, 6-D-dibenzoyl-4, 5-dihydroxyazepane
5c. A mixture of azepane 5c (235 mg, 0.5
rnmole), PPh3 (200 mg, 0.75 mmole), PhC02H
(90 mg, 0.75 mmole), DEAD (115 !!L, 130 mg,
0.75 mmole) and THF (5 mL) was stirred at
room temperature for 48 hr. The solvent was
evaporated under reduced pressure and the resi-
due flash chromatographed over silica gel using
pet. ether-ethyl acetate (3:2) as eluent to afford
(35, 4R*, 5R, 65)-N-benzyl-3, 4, 6-O-tribenzoyl-
5-hydroxyazepane 8 (110 mg, 40%) as a white
solid. m.p. 119-200; IR ; (Neat): 3415, 1717 cm-I;
IH NMR (CDCI3) : 6 2.90 (dd, J= 6 and 12 Hz,
2H), 3.12 (dd, J= 6 and 12 Hz, 2H), 3.30-3.50
(brs, 1H), 3.70 (q, J= 12 Hz, 2H), 4.00-4.18 (m,
2H), 5.14-5.30 (m, 2H), 7.08-7.68 (m, 14H), 8.00
(d, J= 6 Hz, 6H); 13C NMR (CDCi3) : 6 57.8,
63.2, 72.7, 75.9, 127.1, 127.5, 127.9 128.2,
128.7, 129.7, 133.1, 138.1, 166.2; MS (relative in-
tensity): mlz 444 (M+ -121, 5°/~), 105 (70%), 91
(100%).
Further elution of the column with pet. ether-
ethyl acetate (1:3) as eluent afforded the pyrroli-
dine derivative 7 (60 mg, 30%) as a syrupy oil; IR
(KBr): 3312,1721 em-I; IH NMR (CDCI3): 62.80
(dd, J= 6 and 10 Hz, 2H), J.14 (q, J= 12 Hz, 2H).
3.98-4.14 (m, 3H), 4.40 (d, J= 10 Hz, 1H), 4.62 (d
J= 4Hz, 1H), 5.12(d,J=4Hz, 1H), 5.1O(d,J= 4Hz,
1H), 7.22-7.72 (m, 16H), 7.92(d, J= 6 Hz, 2H), 8.02
(d, J= 6 Hz, 2H); i3C NMR (CDClj): 656.61, 58.3
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62.7, 70.9, 72.6, 77.6, 79.7, 127.1, 128.3, 128.8,
129.4,129.6,132.9,133.2,137.5, 166.1, 167.1; MS
(relative intensity): mlz 444 (M+ -122, 4%),
9f(70%), 105 (100%).
Benzoylation of azepane derivative 8. The aze-
pane 8 was benzoylated by the method described
earlier using 8 (113 mg, 0.2 mmole), dry pyridine
(2 mL) and benzoyl chloride (47 fA.L,0.4 mmole)
to afford the tetrabenzoylazepane 10 (92 mg,
70%) as a white solid, m.p. 130-32°; [all? + 25.0°
(c 0.1, CHCI3) [for authentic tetra-O-benzoyl
compound [al65 + 9.8° (c 0.1, CHCl3)l; IR (KBr) :
1717 em-I; IH NMR (CDCl3) : 6 3.12 (dd, J=6
and 12 Hz, 2H), 3.36 (dd, J= 4 and 10 Hz, 2H),
3.88-3.92 (q, J= 12 Hz, 2H), 5.62-5.80 (m, 2H),
6.00-6.12 (m, 2H), 7.06-7.66 (m, 17 H), 7.82 (d,
J= 6 Hz, 4 H), 7.94 (d, J= 6 Hz, 4 H); I3C NMR
(CDCl3) : 6 56.7, 63.1, 72.2, 73.1, 127.3, 128.0,
129.2, 128.8, 129.5, 129.7, 130.1, 132.9, 133.1,
133.6,137.7,165.4.
Benzoylation of pyrrolidine derivative 7. Ben-
zoylation of 7 (56.5 mg, 0.1 mmole) by the above
method using dry pyridine (1 mL) and benzoyl
chloride (35 fA.L,0.3 mmole) afforded the tetra-O-
benzoylpyrrolidine 9 (52 mg, 74%) as a white sol-
id, m.p. 116-18°; [al55 + 17.9° (c 0.15, CHCI3); IR
(KBr): 1721 em-I; IH NMR (CDCI3): 6 3.10 (dd,
J=4 and 10 Hz, 2H), 3.40-3.76 (m, 2H), 4.40 (d,
J= 6 Hz, 1H), 4.70-4.92 (m, 2H), 5.42(d, J= 4
Hz, 1H), 5.90 (d, J=4 Hz, 1H), 6.10 (d, /=4 Hz,
iH), 7.18-7.66(m, 17H), 7.90-8.20 (m, 8H); l3C
NMR (CDCI3) : 657.7, 58.3, 63.6, 68.9, 69.5,
77.0, 78.7, 127.3, 128.3, 128.4, 128.9, 129.2,
129.6, 129.7, 130.0, 133.0, 133.4, 137.1, 165.2,
165.7, 166.1; MS (relative intensity) : m/z 670
(M+ + 1,5%),105 (100%).
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